Guidelines and cautions for deprescribing

Endometriosis-associated pain (1:30), HIV-associated complications (3:30), glucagon-like peptide-1 receptor agonists for obesity in adolescents (7:40), discontinuing antihypertensives (12:40), vertebral compression fractures (14:40), and buprenorphine dosage for opioid use disorder (18:30).